Rep. Jennifer Wexton of Virginia was diagnosed last year with rare disease that makes it hard to speak. She still advocated for a bill renaming a post office in her district – and the House passed it.

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

Arts therapies appear to ease brain disorders from Parkinson's to PTSD. Now, artists and scientists have launched an effort to understand how these treatments change the brain.